News | Focused Ultrasound Therapy | April 05, 2016

New Video Features Focused Ultrasound as Breakthrough Medical Treatment

Eight-minute video profiles patients with various diseases who have been helped by focused ultrasound therapy

April 5, 2016 — The Focused Ultrasound Foundation has produced a video that demonstrates the potential of this new medical technology to revolutionize the treatment of many serious disorders. The short film captures the experience and insights of patients, international researchers, physicians, industry leaders and other supporters of this “breakthrough transformational approach.”

The video features the story of Rick – a patient who felt embarrassed and inadequate because of his tremor. Rick’s outlook was transformed following focused ultrasound treatment at the University of Maryland. The video shows his challenges with conducting simple tasks, chronicles his treatment and captures him drinking steadily from a glass of water just minutes after the procedure — for the first time since childhood. “Focused ultrasound can give someone a new lease on life,” he stated.

Other patients profiled include:

  • Kimberly – a woman with Parkinson’s who is able to get back on her bike after treatment in a clinical trial;
  • Jack – a teenager who is able to play sports again thanks to the non-invasive treatment that eliminated pain caused by a bone tumor; and
  • Elizabeth – who regained her freedom after seeking relief from fibroid symptoms.

“Focused ultrasound treatment has given me back my life - it is a miracle,” said Parkinson’s patient Kimberly.

The 8-minute video also includes 15 experts talking about the potential of focused ultrasound from institutions like Stanford, the University of Virginia, Children’s National Medical Center and Sapienza University of Rome. Animation is used to demonstrate how beams of sound that harmlessly penetrate healthy tissue can be focused to treat a target deep in the body without incisions or other risks of traditional surgery. The therapy has the potential to transform treatment for a range of conditions, including Parkinson’s, Alzheimer’s, depression, pancreatic cancer, prostate cancer, hypertension and brain tumors.

Former National Cancer Institute (NCI) Director and Commissioner of the U.S. Food and Drug Administration (FDA) Andrew von Eschenbach, M.D., urges viewers to take action to support the technology. He closes the video with the statement, “Nothing happens in society unless people want it to. So when people stand up and say ‘we want this,’ then we will do it.”

For more information: www.fusfoundation.org

Related Content

IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring
News | Radiation Therapy | October 17, 2018
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the...
Boston Scientific Closes Acquisition of Augmenix Inc.
News | Prostate Cancer | October 17, 2018
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel...
Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition
News | Patient Engagement | October 15, 2018
Varian announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based,...
New Guideline for Prostate Cancer Supports Shortened Radiation Therapy
News | Prostate Cancer | October 12, 2018
Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate...
Surgery, Radiation Therapy Equally Effective in Treating Oropharyngeal Cancer
News | Radiation Therapy | October 09, 2018
A new study by researchers at UT Southwestern Medical Center found no major long-term differences in the effectiveness...
ASTRO 2018 Radiation Therapy Clinical Trials
Feature | ASTRO | October 08, 2018
October 8, 2018 — The American Society for Radiation Oncology (ASTRO) announced the 10 top-rated clinical studies tha
Videos | Treatment Planning | October 08, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri
ViewRay and Miami Cancer Institute Host Symposium on MR-Guided Radiation Therapy
News | Image Guided Radiation Therapy (IGRT) | October 05, 2018
October 5, 2018 — Leading oncology experts from around the world recently met to discuss the integration of...
Videos | Treatment Planning | October 05, 2018
Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, descri